Labcorp deploys new SARS-CoV-2 sequencing panel

By staff writers

June 22, 2021 -- Labcorp will start using Molecular Loop Biosciences' SARS-CoV-2 research sequencing panel to sequence thousands of complete coronavirus genomes each week from positive patient samples.

The panel converts extracted RNA samples into sequencer-ready libraries in four steps to make it easy to implement and scale for Illumina or PacBio sequencing. Redundant probe tiling technology means emerging variants are detected and the concern about amplicon or allele dropouts that can occur in amplicon-based workflows is alleviated.

The sequencing is part of a U.S. Centers for Disease Control and Prevention (CDC) initiative to identify and track the spread of SARS-CoV-2 variants throughout the country.

OmniSeq, Labcorp launch new oncology test
OmniSeq and Labcorp have launched OmniSeq Insight, a new test based on next-generation sequencing that's intended to help improve oncology treatment and...
Labcorp to buy intellectual property from Myriad Genetics
Labcorp plans to buy some of Myriad Genetics' operating assets and intellectual property from its autoimmune business unit, including its Vectra rheumatoid...
Labcorp adds new COVID-19 antigen test to repertoire
Labcorp has added a new high sensitivity antigen test for screening for active COVID-19 disease to its testing offerings. The nasal swab test was developed...
CDC awards Labcorp SARS-CoV-2 sequencing contract
The U.S. Centers for Disease Control and Prevention (CDC) has awarded Labcorp a contract to provide genomic sequencing of samples of the SARS-CoV-2 virus.
Labcorp gets EUA for Pixel at-home COVID-19 kits
Labcorp has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for Pixel by Labcorp, a kit that will enable users...

Copyright © 2021

Last Updated ls 6/22/2021 1:16:08 PM